How does LONNE's PE Ratio compare to its peers?

LONNE is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the peer average (37.4x).

How does LONNE's PE Ratio compare vs other companies in the European Life Sciences Industry?

LONNE is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the European Life Sciences industry average (37.5x).

What is LONNE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LONNE is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the estimated Fair Price-To-Earnings Ratio (30.9x).

What is the Fair Price of LONNE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

LONNE (CHF531.8) is trading below our estimate of [[fair value]] (CHF1116.9)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

LONNE Stock Overview

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. More details

LONNE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	1/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 52.4% below our estimate of its fair value

Earnings are forecast to grow 23.38% per year

Risk Analysis

Profit margins (8.6%) are lower than last year (17.9%)

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

Lonza Group AG Competitors

Siegfried Holding

SWX:SFZN

CHF 4.2b

Bachem Holding

SWX:BANB

CHF 4.3b

Tecan Group

SWX:TECN

CHF 2.6b

SKAN Group

SWX:SKAN

CHF 1.7b

Price History & Performance

Summary of share price highs, lows and changes for Lonza Group
Historical stock prices
Current Share Price	CHF 531.80
52 Week High	CHF 589.00
52 Week Low	CHF 340.60
Beta	0.64
1 Month Change	-0.038%
3 Month Change	-1.45%
1 Year Change	50.61%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-2.46%

Recent updates

Shareholder Returns

	LONNE	CH Life Sciences	CH Market
7D	0.7%	0.3%	0.6%
1Y	50.6%	27.4%	2.3%

Return vs Industry: LONNE exceeded the Swiss Life Sciences industry which returned 27.4% over the past year.

Return vs Market: LONNE exceeded the Swiss Market which returned 1.5% over the past year.

Price Volatility

Is LONNE's price volatile compared to industry and market?
LONNE volatility
LONNE Average Weekly Movement	3.7%
Life Sciences Industry Average Movement	4.6%
Market Average Movement	3.3%
10% most volatile stocks in CH Market	7.5%
10% least volatile stocks in CH Market	1.6%

Stable Share Price: LONNE has not had significant price volatility in the past 3 months compared to the Swiss market.

Volatility Over Time: LONNE's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1897	17,834	Wolfgang Wienand	www.lonza.com

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.

Lonza Group AG Fundamentals Summary

How do Lonza Group's earnings and revenue compare to its market cap?
LONNE fundamental statistics
Market cap	CHF 38.45b
Earnings (TTM)	CHF 573.00m
Revenue (TTM)	CHF 6.70b

67.1x

P/E Ratio

5.7x

P/S Ratio

Is LONNE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LONNE income statement (TTM)
Revenue	CHF 6.70b
Cost of Revenue	CHF 4.29b
Gross Profit	CHF 2.41b
Other Expenses	CHF 1.84b
Earnings	CHF 573.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Jan 29, 2025

Earnings per share (EPS)	7.93
Gross Margin	36.01%
Net Profit Margin	8.56%
Debt/Equity Ratio	40.3%

How did LONNE perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

50%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 07:23
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lonza Group AG is covered by 50 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Martin Schnee	AlphaValue
Volker Bosse	Baader Helvea Equity Research
Charles Pitman-King	Barclays